One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

Drug developed in Cambridge approved for treatment of multiple sclerosis

Published on 20 September, 2013

Approval concludes nearly 40-year epic journey from fundamental research, begun at LMB, to discovery of an effective treatment for active relapsing multiple sclerosis. More…